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AbstrACt 
Objectives This study aimed to identify the extent 
of tobacco cessation training content, including the 
introduction of a comprehensive programme; and the 
presence of tobacco-related topics, including new tobacco 
products, school years and course of training, educators, 
and attitudes and policies relevant to tobacco education in 
pharmacy schools in Japan.
Design A cross-sectional survey.
setting All pharmacy schools in Japan with a 6-year 
course of training were invited to participate.
Methods Pharmacy schools in Japan that agreed to 
participate in a web-based survey asking about tobacco 
cessation training, and attitudes and policies relevant to 
tobacco education.
Primary and secondary outcome measures The 
primary outcome was the number of pharmacy schools 
that introduced comprehensive tobacco cessation training 
in their curriculum. The secondary outcome was to clarify 
the curriculum coverage of 9 basic knowledge and 10 
tobacco cessation-specific topics, including new tobacco 
products.
results Of the 75 pharmacy schools with a 6-year 
course in Japan, 52 (74%) responded to the survey. While 
27 (52%) schools reported that comprehensive tobacco 
cessation training would be beneficial, only 1 school had 
introduced it as a one-credit elective course in the fifth 
year. Basic knowledge topics for tobacco cessation listed 
in or related to the Model Core Curriculum were covered 
by 44%–65% of the schools, while practical skills were 
covered in 10%–19% of the schools. Only seven schools 
(14%) introduced the topic of new tobacco products in 
their curriculum.
Conclusions This study revealed that comprehensive 
tobacco cessation training is not generally offered in 
pharmacy schools in Japan. The Model Core Curriculum 
should revise its standards to implement updated tobacco 
cessation training programmes to keep up with new 
tobacco products and to train pharmacy students on 
counselling users of such products.
trial registration number Tokyo University of Pharmacy 
and Life Sciences No. 17 – 14.
IntrODuCtIOn
While cigarette smoking has decreased at the 
global level over the past 30 years,1 tobacco 
smoking is one of the main risk factors for 
non-communicable diseases,2 causing 11.5% 
(6.4 million) of global deaths in 2015.3 Japan 
ranks seventh among the top 10 countries 
with the highest smoking population (China, 
India, Indonesia, the USA, Russia, Bangla-
desh, Japan, Brazil, Germany and the Philip-
pines).3 In Japan, while adult smoking rates 
declined over the 10-year period from 2007 
(39.4% of men and 11.0% of women) to 2017 
(29.4% of men and 7.2% of women),4 more 
than 157 800 of its people are killed annu-
ally by tobacco-caused non-communicable 
diseases.5 Because tobacco smoking and high 
blood pressure are the two major risk factors 
for adult mortality from non-communicable 
diseases in Japan, there is a major potential 
for population health gain if these factors are 
controlled.6 
Smoking cessation is a major means of 
preventing smoking-related deaths worldwide. 
Healthcare professionals who receive training 
in smoking cessation are more likely to assess 
smoking status and assist their patients with 
quitting, compared with untrained controls.7 
Pharmacists, who are highly accessible health-
care professionals, should be poised to offer 
effective tobacco cessation programmes to 
patients. This is especially true in the USA 
and in several other countries, where basic 
knowledge of and practical skills for tobacco 
cessation counselling, in the form of compre-
hensive tobacco cessation training, are taught 
to most pharmacy students.8–10 According to 
the recommendations of Rx for Change, the 
world’s first comprehensive evidence-based 
strengths and limitations of this study
 ► This is the first study to evaluate whether tobacco 
cessation topics are covered in the curricula of phar-
macy schools in Japan.
 ► This survey was undertaken in a country with rapid 
growth of the market for heated tobacco products.
 ► The results might overestimate the curricular cover-
age of tobacco cessation training provided in phar-
macy schools, because the data were self-reported.
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tobacco cessation training programme,11 the ideal 
tobacco cessation training is to (1) expand tobacco cessa-
tion content into the curriculum, (2) ensure at least one 
faculty member has the necessary knowledge and skills 
to teach tobacco cessation and (3) dedicate 8 hours to 
tobacco cessation content.10 12 To ensure that future phar-
macists graduate with the knowledge and skills to solve 
public health problems, including tobacco dependence, 
health institutions and educational centres must include 
tobacco control in curricula and continuing educa-
tion.12 13
In Japan, there are currently 75 pharmacy schools 
offering a 6-year training programme, which, together, 
have a total enrolment of 11 502 students per year.14 
Although the Japanese Model Core Curriculum for Phar-
maceutical Education V.2015 was devised to fit the WHO 
eight-star pharmacist concept to ensure optimal phar-
maceutical care and decision-making,15 it has neglected 
tobacco cessation training. The Model Core Curriculum 
constitutes most (70% of credits) of the pharmacy curric-
ulum in every school across Japan, with the remaining 
30% being unique to each school.16 Because the extent to 
which tobacco cessation education included in the curric-
ulum depends on each school, we assessed the curricular 
coverage of tobacco cessation education provided in the 
pharmacy schools in Japan.
In addition, to assess the curricular coverage of basic 
knowledge of tobacco cessation training and the related 
practical skills, we aimed to identify the extent of incor-
poration of the health effects of new tobacco products, 
including heated tobacco products. While cigarettes have 
generally been the most popular tobacco product in 
Japan (as opposed to traditional options, such as cigars, 
pipes and oral snuff), heated tobacco products accounted 
for 20.9% of Japan’s tobacco market in 2018 versus 12% 
in 2017.17 Branded types of heated tobacco products sold 
in Japan include tobacco microcapsules (Ploom), sticks 
(Glo) and mini-cigarettes (IQOS), which are designed to 
heat tobacco for avoiding combustion to generate nico-
tine aerosol. Because nicotine-containing e-cigarettes are 
regulated under the Japanese Pharmaceutical Affairs Law, 
as a pilot testing area, Japan accounted for more than 
90% of the heated tobacco products market among more 
than 30 countries in 2017.18 According to a WHO report, 
at present, there is no evidence that heated tobacco 
products are less harmful than conventional tobacco.19 
Because heated tobacco products and e-cigarettes have 
been gaining popularity,20 pharmacists will be required 
to provide counselling to users of those products. Given 
that tobacco cessation training should be tailored to each 
country’s circumstances,21 we also measured coverage 
of heated tobacco products in the tobacco cessation 
curricula of pharmacy schools in Japan.
MethODs
study design
The study involved a cross-sectional web-based survey.
setting and participants
Because we targeted all 75 accredited pharmacy schools 
offering 6-year training programmes to educate pharma-
cists in Japan, we had no exclusion criteria. We sent these 
schools a survey invitation letter, requesting one faculty 
member who was responsible for coordinating school 
courses to respond to a web-based survey through Survey-
Monkey (SurveyMonkey, Palo Alto, CA, USA) in February 
2018. Data were collected from February to June 2018. 
This was followed by two reminder letters in March and 
April, and a telephone call in May 2018. The study was 
conducted at Tokyo University of Pharmacy and Life 
Sciences (TUPLS). The study protocol was approved by 
the institutional review board of TUPLS.
Measures
We collected information using an 18-item survey, titled 
‘Questionnaire about Tobacco Cessation Education in 
Six-Year Pharmacy Schools’ (online supplementary file 
1), consisting of a combination of closed- and open-
ended questions.
Variables
The primary outcome was to identify the number of phar-
macy schools that introduced comprehensive tobacco 
cessation training in their curriculum. We defined compre-
hensive tobacco cessation training as providing pharmacy 
students with tobacco cessation–related knowledge and 
skills in one course. The secondary focus was to clarify the 
curriculum coverage of 9 basic knowledge and 10 prac-
tical topics, including new tobacco products, for tobacco 
cessation training. We defined those tobacco cessation–
related educational contents based on the Rx for Change 
programme.11 Our dependent variable measured the 
total number of tobacco cessation training topics that 
the school covered, which presented an overall picture 
of the coverage of the comprehensive tobacco cessation 
training programmes.
We collected the following information through the 
survey: (1) whether or not the school had introduced 
tobacco cessation training programmes as a required/
elective course (one item); (2) whether or not tobacco 
cessation training should be introduced in pharmacy 
education (one item); (3) school curriculum coverage 
of each tobacco cessation training topic (four items); (4) 
smoke-free/tobacco-free policies on campus (six items); 
(5) whether the school offered tobacco education for 
students and staff (three items); and (6) characteristics 
of the participating pharmacy schools (three items): 
public/private, location, and respondent’s name and 
e-mail address (optional). Regarding introduced topics, 
additional questions addressed the style of education, 
including the ways in which tobacco cessation training is 
integrated into curricula; the student year in which the 
educational content is offered; methods of learning, that 
is, lectures or problem-based learning; and the teach-
er’s background (faculty member or external lecturer; 
whether or not a board-certified member of the Japan 
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Society for Tobacco Control as a tobacco cessation 
specialist; and physician, nurse, pharmacist with/without 
clinical expertise). Information on policies was collected 
to provide potential confounders in the process of intro-
ducing tobacco-related topics in school curricula.22 
We assessed whether the school had written policies 
regarding a campus smoking ban, tobacco cessation 
initiatives, protection from secondhand smoke exposure 
and new tobacco product use.
Patient and public involvement
Because the survey focused on topics of tobacco cessa-
tion training among pharmacy schools, patients were not 
directly involved in this study.
statistical analysis
All data were analysed using JMP Pro V.14 (SAS Institute, 
Cary, NC, USA). Because we aimed to make an inven-
tory of tobacco cessation training in pharmacy curricula 
in Japan, we requested all 6-year pharmacy schools to 
answer the questionnaire. We estimated a response rate 
of approximately 70% (52 schools) based on a previous 
survey regarding pharmacy education in Japan.23 To 
summarise the responses, values were reported as means 
and SD, ranges or frequency in percentages. We compared 
the characteristics of the participating pharmacy schools 
and the survey responses using Fisher’s exact test for cate-
gorical variables and analysis of variance for continuous 
ones.
Our assumption regarding the ideal sample size was ≥47 
participants and included an SD of 5 with a two-sided 
significance level, 80% power and 5% α-error. In that 
calculation, we estimated that the mean was nine topics 
(four listed and five related) in the schools that intro-
duced tobacco cessation training in their coursework; two 
other groups only listed four topics: one did not deliver 
tobacco cessation training, and another had been consid-
ering their implementation.
All probability values for statistical analyses were 
two-tailed, and p<0.05 was regarded as statistically 
significant.
results
study flow
Of the 57 private and 18 public pharmacy schools in 
Japan, 55 responded to the survey (73% response rate). 
School location did not significantly differ between 
respondents and non-respondents. Three schools were 
excluded because of missing data on all 19 tobacco cessa-
tion training topics (online supplementary file 2).
Characteristics of participating pharmacy schools
The characteristics of the pharmacy schools that partici-
pated in this study are shown in table 1. Most were private 
schools (83%). Of the 52 responding schools, only one 
school responded that it conducted a comprehensive 
tobacco cessation training programme in the curriculum; 
27 (52%) schools reported that it would be preferable to 
introduce tobacco cessation training in pharmacy educa-
tion. Reasons for implementing such training included 
tobacco cessation support being a duty of pharmacists 
(n=18, 67%), the need for students to know about the 
health consequences of smoking/nicotine addiction 
(n=5, 19%) and such training serving as an excellent 
opportunity for students to quit smoking themselves (n=2, 
2%). Conversely, of the 52 schools, 6 (12%) reported that 
tobacco cessation training was not needed in pharmacy 
education, and 19 (37%) were not sure of the necessity 
of introducing such a training programme. The reasons 
they cited for not implementing the training were that 
tobacco cessation training is not listed as an objective of 
the Model Core Curriculum (n=18, 35%), there is a lack 
of space for such training in the school curriculum (n=5, 
9.6%), and such material could be learnt during their 
clerkships in the fifth year (n=2, 4%).
Although half of the pharmacy schools offered educa-
tion for non-use of tobacco at the first-year students’ 
orientation (55%), tobacco cessation programmes were 
not commonly offered to either students or staff (10% 
and 18%, respectively).
Curricular coverage of learning topics for tobacco cessation 
training
Only one school conducted a comprehensive tobacco 
cessation training programme in an elective course in the 
fifth year (table 1). This school implemented 16 topics 
(eight basic knowledge aspects and eight skills, including 
health effects of new tobacco products) of the 19 total 
topics for a tobacco cessation training programme. The 
total number of tobacco cessation training topics covered 
in the curriculum did not differ by school type, location, 
campus tobacco control policies and tobacco education 
for institution members. Pharmacy schools that had a 
positive attitude to the introduction of a tobacco cessa-
tion training programme or a positive attitude towards 
a campus smoking ban covered more tobacco cessation 
training topics in their curriculum than other pharmacy 
schools, which did not have these. Curricular coverage 
of the nicotine pharmacology effect and principles of 
nicotine addiction, which were listed in the Model Core 
Curriculum, were not significantly different among 
subgroups of the perceived importance of tobacco cessa-
tion training in pharmacy education (online supplemen-
tary file 3). However, regarding the curricular coverage of 
topics not listed in the Model Core Curriculum, practical 
skills were almost absent.
Table 2 shows curricular coverage, school years and the 
course of learning topics for tobacco cessation training 
in responding pharmacy schools in Japan. Regarding 
basic knowledge of tobacco cessation training listed in/
related to the Model Core Curriculum, around 40%–60% 
of pharmacy schools reported coverage in core/elective 
classes in the median third year (IQR: second to fourth 
year). Curricular coverage of the nicotine pharmacology 
effect and principles of nicotine addiction were 65% and 
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Table 1 Total of all tobacco cessation training topics covered by participating pharmacy schools
Characteristics n (%)
Tobacco cessation training 
topics covered by schools P value for 
difference mean (SD)
Basic backgrounds (n=52)
  School Type
   Public 9 (17) 4.1 (5.5) 0.36
   Private 43 (83) 5.9 (5.3)
  School area
   Hokkaido or Tohoku 6 (12) 4.3 (3.7) 0.29
   Kanto 16 (31) 4.5 (5.4)
   Hokuriku or Tokai 5 (10) 6.2 (5.1)
   Kinki 13 (25) 4.7 (5.2)
   Chugoku or Kyushu 12 (23) 8.5 (5.8)
School attitude to tobacco cessation training programme introduction (n=52)
  School has a tobacco cessation training programme in a core/elective course
   Yes 1 (2) 16.0 (-) <0.001
   Under consideration 4 (8) 13.0 (4.7)
   No 47 (90) 4.8 (4.7)
  Tobacco cessation training programme should be introduced in pharmacy education
   Yes 27 (52) 7.8 (5.9) 0.007
   No 6 (12) 2.7 (2.8)
   Not sure 19 (37) 3.5 (3.7)
School attitude to campus smoking ban (n=51)
  Smoking ban on campus
   No exceptions 30 (59) 5.9 (5.3) 0.31
   Indoor only 15 (29) 6.5 (5.5)
   With designated smoking area 6 (12) 2.7 (4.8)
  New tobacco products use indoor
   Available 14 (28) 5.7 (5.5) 0.99
   Unavailable 37 (73) 5.7 (5.3)
  Campus smoking ban should be introduced in pharmacy schools
   Yes 38 (75) 6.6 (5.4) 0.02
   No 1 (2) 12.0 (-)
   Not sure 12 (24) 2.3 (3.3)
Campus policies for tobacco control (n=50)
  Smoke-free prohibition policies
   Yes 27 (54) 6.5 (5.3) 0.22
   Under consideration 7 (14) 7.6 (5.4)
   No 16 (32) 4.0 (4.8)
  Tobacco cessation initiatives
   Yes 13 (26) 7.2 (5.4) 0.49
   Under consideration 7 (14) 6.3 (3.3)
   No 30 (60) 5.1 (5.4)
  Secondhand smoke exposure policy
   Yes 14 (28) 7.6 (4.9) 0.13
   Under consideration 8 (16) 8.0 (5.1)
   No 28 (56) 4.4 (5.1)
Continued
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52%, respectively. However, regarding practical skills for 
tobacco cessation training, around 10%–20% of phar-
macy schools reported coverage in the median fourth 
year (IQR: third to fifth year). Seven (14%) schools 
reported covering both ‘forms of tobacco used in Japan’ 
and ‘health effects of new tobacco products, including 
heated tobacco products’ in the median third year. Both 
basic knowledge of and practical skills for tobacco cessa-
tion training were taught over multiple years.
We counted the total number of tobacco cessation 
training topics, which presented an overall picture of 
the school coverage of the tobacco cessation training 
programme. Overall, the mean coverage (SD) was 5.6 
(5.3) topics in responding pharmacy schools, corre-
sponding to 30% of the total tobacco cessation training 
topics.
Educators for tobacco cessation training
Various lecturers taught fragmented tobacco cessation 
training topics across multiple courses (table 3). Faculty 
members mainly taught both basic knowledge and prac-
tical skills (81% and 93% for each trainer, respectively). 
Pharmacists with clinical expertise were the main educa-
tors (33% for basic knowledge trainer and 43% for 
practical skills trainer). In addition, the use of tobacco 
cessation specialists, including external lecturers, was low 
(5% and 7%, respectively).
DIsCussIOn
We found that a comprehensive tobacco cessation 
training programme incorporating topics focusing on 
tobacco cessation in one course was introduced in only 
one pharmacy school in Japan. The topic of new tobacco 
and practical skills for tobacco cessation training, which 
were not listed in the Model Core Curriculum, were 
covered by 10%–20% of the schools. Certified tobacco 
cessation specialists were used by 5%–7% of tobacco 
cessation training educators.
Basic knowledge topics for tobacco cessation listed in 
or related to the Model Core Curriculum were covered 
by 44%–65% of the schools, while practical skills were 
covered in less than 20% of responding schools. The Model 
Core Curriculum does not specifically address, define 
or require comprehensive tobacco cessation training; it 
requires education regarding tobacco-related diseases, 
including nicotine dependence, as well as disease state, 
for example, pathophysiology and symptoms. Pharmacy 
schools in Japan seem to be likely meeting the minimum 
requirements of the Model Core Curriculum. However, 
comprehensive tobacco cessation training would need to 
be a required coursework of pharmacy curricula in Japan 
to ensure that all pharmacy students possess evidence-
based knowledge and skills to help patients quit tobacco 
use,11 like most pharmacy colleges/schools in the USA 
(99%) and Malaysia (81%), which integrate tobacco 
cessation content into their coursework.8 12 It would be 
preferable to introduce all topics on tobacco cessation in 
a short-term intensive course; however, it could be permis-
sible for several faculty members to teach the material 
across multiple courses, if the curriculum is difficult to 
change or there is limited time.
Based on our survey, offering a tobacco cessation 
training programme around the third or fourth years 
would be reasonable; in this way, during their clerk-
ships in the fifth year, pharmacy students could have an 
opportunity to advise patients to quit tobacco. Several 
schools expected that tobacco cessation training would 
be covered during their clerkships. However, pharmacy 
students are not likely to have enough opportunities to 
observe tobacco cessation interventions by pharmacists or 
Characteristics n (%)
Tobacco cessation training 
topics covered by schools P value for 
difference mean (SD)
Tobacco education for institution members (n=51)
  School offers education for non-use of tobacco for students
   Yes 28 (55) 7.1 (4.9) 0.07
   Previously offered 3 (6) 7.0 (0.6)
   No 20 (39) 3.6 (4.4)
  School offers smoking cessation programme for students
   Yes 5 (10) 6.8 (4.9) 0.06
   Previously offered 4 (8) 11.5 (5.9)
   No 42 (82) 5.0 (4.8)
  School offers smoking cessation programme for staff
   Yes 9 (18) 6.4 (5.4) 0.90
   Previously offered 3 (6) 6.0 (1.5)
   No 39 (77) 5.5 (5.3)
Table 1 Continued 
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to learn about tobacco-related diseases during their clerk-
ships in the fifth year.24
The topic of the various forms of tobacco—not listed 
in the Model Core Curriculum—was rarely covered by 
the surveyed pharmacy schools. Because heated tobacco 
products and electronic cigarettes have been gaining 
popularity,20 future pharmacists will be required to 
provide counselling to users of these products, as well 
as users of traditional tobacco products. A recent study 
recommended that targeted training on how to counsel 
patients on e-cigarette cessation should be included in 
pharmacy curricula in the USA.25 Also, in Japan, where 
heated tobacco products are the most prevalent, tobacco 
cessation training that includes information on new 
tobacco products should be introduced as needed.
Although academic clinical pharmacists were the main 
tobacco cessation training educators, almost none of them 
were certified tobacco cessation specialists. In the USA, 
the national train-the-trainer programme is conducted as 
a ‘14.5-hour, 3=day course’ before the implementation of 
the tobacco cessation training programme in pharmacy 
schools,26 and a ‘6 hour web-based Rx for Change train-
the-trainer programme’ for pharmacy faculty who wish 
to teach tobacco cessation is underway.12 Introducing a 
similar ‘train-the-trainer programme’ should be useful for 
Japan as well as other countries where these educational 
systems have not yet prepared. In addition, the creation 
of board-certificated tobacco cessation specialists within 
the realm of tobacco cessation training would be ideal for 
teachers.
This study has several limitations. First, this paper 
included only self-reported outcomes by faculty members 
who were responsible for coordinating school courses. It 
would be preferable to ask them directly about the extent 
of the tobacco cessation training programme in their 
respective school’s curriculum, because few pharmacy 
schools introduced those. Second, we did not look into 
the time spent on each topic, the resources used, or the 
outcomes, although we did note that few schools used 
tobacco cessation specialists as lecturers. Past studies have 
indicated a lack of consistency in healthcare professionals’ 
tobacco/nicotine education27; therefore, further research 
should be conducted to take a more practical approach 
to train pharmacy students and pharmacists in Japan. 
Third, because this was a cross-sectional study, there is the 
possibility of potential bias: the extent to which research-
funding institutions established by tobacco companies 
influenced faculty members to develop school curricula 
is unclear.28 Despite these limitations, this study provides 
information about the need for more tobacco education 
in pharmacy training programmes in Japan.
Tobacco cessation counselling is an essential public 
health service provided by pharmacists worldwide. Because 
tobacco smoking and high blood pressure are the two 
major risk factors for adult mortality from non-communi-
cable diseases in Japan, the provision of tobacco cessation 
and hypertension counselling by pharmacists would be 
beneficial. To deliver such services sustainably, incorpo-
ration into the pharmacy curriculum is advocated.29 In 
countries where new tobacco products, including heated 
tobacco products, are spreading, pharmacy education 
should introduce tobacco cessation training programmes 
to counsel people on their risks, because it is untrue that 
IQOS use is unassociated with the adverse cardiovascular 
effects of smoking cigarettes.30
COnClusIOns
This study revealed that pharmacy schools in Japan 
generally do not include comprehensive tobacco cessa-
tion training programmes. Most pharmacy schools do not 
introduce the topic of new tobacco products. With newer 
tobacco products continually being developed, there is a 
need for upgrading cessation education and adequately 
educating pharmacists. The Model Core Curriculum in 
pharmacy education should revise its standards to include 
tobacco–nicotine cessation training.
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